Alphabet's life-science subsidiary Verily is teaming up with cosmetics giant L'Oréal in an effort to better understand skin care and develop new digital tools in the dermatology space. The partners plan to study dermatological health over time to better understand the environment and aging's impact on skin and the "deep biology of the skin."
Verily's R&D team and L'Oréal's Active Cosmetic...
Last week, L'Oréal announced that its La Roche-Posay My Skin Track UV—the first battery-free wearable electronic to measure UV exposure is available for sale through apple.com and select U.S. Apple Store locations.
La Roche-Posay My Skin Track UV measures both UVA and UVB rays, and provides instant status updates while storing up to three months of data. The battery-free sensor is activated by...
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...
Connected wearable patch makers will ship 35.1 million units annually by 2022, with 80 percent of these being used in clinical applications, according to a recent report from market intelligence firm Tractica.
The report also forecasts a total $7.9 billion in revenue for the patch market by the same year, all of which suggests a substantial escalation from the 966,000 units the analysts wrote...
L’Oreal made one of the most talked about digital health announcements at CES this year when the company unveiled an smartphone-connected adhesive patch that monitors a user’s UV exposure. Earlier this week, in an interview with Fast Company, L’Oreal shared more details about this new offering as well as the company’s entry into tech.
"There is an inherent disconnect between people and...
